Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Self-complementary oligodeoxyribonucleotides containing 2'-O-(anthraquinone-2-methyl)adenosine

H M Deshmukh1, S P Joglekar, A D Broom

  • 1Department of Medicinal Chemistry, College of Pharmacy, University of Utah, Salt Lake City 84112, USA.

Bioconjugate Chemistry
|September 1, 1995
PubMed
Summary

Adding an intercalating agent to oligodeoxynucleotides (ODNs) enhances their binding affinity and stability. This modification increases hydrophobicity and nuclease resistance for improved ODN performance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

5,6-Diaminocytidine, a versatile synthon for pyrimidine-based bicyclic nucleosides.

Organic letters·2000
Same author

PMTI, a broadly active unusual single-stranded polyribonucleotide, inhibits human immunodeficiency virus replication by multiple mechanisms.

Antiviral chemistry & chemotherapy·1999
Same author

Antiviral oligo- and polyribonucleotides containing selected triazolo[2,3-a]purines.

Journal of medicinal chemistry·1998
Same author

Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells.

Pharmaceutical research·1998
Same author

Opportunities in drug discovery for treatment of AIDS.

Pharmaceutical research·1998
Same author

Nonclassical 2,4-diamino-8-deazafolate analogues as inhibitors of dihydrofolate reductases from rat liver, Pneumocystis carinii, and Toxoplasma gondii.

Journal of medicinal chemistry·1996

Area of Science:

  • Oligonucleotide chemistry
  • Molecular biology
  • Biophysical chemistry

Background:

  • Oligodeoxynucleotides (ODNs) are short DNA strands with therapeutic and diagnostic potential.
  • Modifications to ODNs can improve their stability, binding affinity, and cellular uptake.
  • Intercalating agents offer a strategy to enhance ODN properties through structural changes.

Purpose of the Study:

  • To synthesize and characterize an oligodeoxynucleotide (ODN) modified with an anthraquinone intercalating agent.
  • To investigate the structural and biophysical effects of site-specific intercalation within an ODN duplex.
  • To evaluate the impact of intercalation on ODN stability, hydrophobicity, and nuclease resistance.

Main Methods:

  • Synthesis of a modified adenosine nucleoside (rA*) with an anthraquinone moiety.

Related Experiment Videos

  • Incorporation of rA* into a palindromic dodecanucleotide sequence (d(CGCrA*CATGTGCG)).
  • Characterization using melting temperature analysis, circular dichroism (CD) spectroscopy, NMR spectroscopy (1D, 2D DQF-COSY, NOESY), and molecular modeling.

    • Main Results:

    • Successful site-specific intercalation of the anthraquinone ring into the ODN duplex was confirmed.
    • The intercalation occurred between specific base pairs (A4-T9 and C5-G8) within a predominantly B-type helix.
    • The modified ODN exhibited significantly enhanced duplex stability and increased hydrophobicity compared to the unmodified control.

    Conclusions:

    • The incorporation of an anthraquinone intercalating agent into an ODN is a viable strategy to enhance its structural and functional properties.
    • Site-specific intercalation leads to significant stabilization of the ODN duplex.
    • This modification holds promise for developing more robust and effective ODN-based therapeutics and research tools.